Litcius/Paper detail

Pharmaceutical Salts of Piroxicam and Meloxicam with Organic Counterions

Shan Huang, Dean S. Venables, Simon E. Lawrence

2022Crystal Growth & Design14 citationsDOIOpen Access PDF

Abstract

Piroxicam (PRM) and meloxicam (MEL) are two nonsteroidal anti-inflammatory drugs, belonging to the Biopharmaceutics Classification System Class II drugs. In this study, six novel pharmaceutical salts of PRM and MEL with three basic organic counterions, that is, 4-aminopyridine (4AP), 4-dimethylaminopyridine (4DMP), and piperazine (PPZ), were prepared by both slurrying and slow evaporation. These salts were characterized by single-crystal and powder X-ray diffraction, thermal analysis, and Fourier transform infrared spectroscopy. All six salts, especially MEL-4DMP and MEL-4AP, showed a significantly improved apparent solubility and dissolution rate in sodium phosphate solution compared with the pure APIs. Notably, PRM-4AP and PRM-4DMP salts exhibited enhanced fluorescence, and the PRM-PPZ salt showed weaker fluorescence compared with that of pure PRM due to different luminescence mechanisms.

Topics & Concepts

ChemistryMeloxicamBiopharmaceutics Classification SystemCounterionSolubilityPiperazinePiroxicamFourier transform infrared spectroscopyNuclear chemistrySalt (chemistry)Organic chemistryPharmacologyIonChemical engineeringPathologyEngineeringMedicineAlternative medicinePhenothiazines and Benzothiazines Synthesis and ActivitiesCrystallography and molecular interactionsLuminescence and Fluorescent Materials